Immunicom Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Immunicom's estimated annual revenue is currently $6.7M per year.(i)
  • Immunicom's estimated revenue per employee is $155,000

Employee Data

  • Immunicom has 43 Employees.(i)
  • Immunicom grew their employee count by -12% last year.

Immunicom's People

NameTitleEmail/Phone
1
VP Strategic PlanningReveal Email/Phone
2
VP Business OperationsReveal Email/Phone
3
VP Regulatory AffairsReveal Email/Phone
4
Chief Commercial OfficerReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Director, Product DevelopmentReveal Email/Phone
7
Medical Director, InternationalReveal Email/Phone
8
Chief Clinical OfficerReveal Email/Phone
9
CEO/FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$32.1M13134%N/AN/A
Add Company

What Is Immunicom?

Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients' quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy has the potential to allow the body's natural immune system to directly attack the cancer while enhancing the effects of other cancer treatments which may be used concurrently. At Immunicom we are reimaging how healing should be.

keywords:N/A

N/A

Total Funding

43

Number of Employees

$6.7M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Immunicom News

2022-04-20 - Immunicom Presents New Data at AACR 2022 of LW-02 ...

Immunicom Presents New Data at AACR 2022 of LW-02 Cartridge Immunopheresis® Therapy from Ongoing mTNBC Clinical Trial in Chemo-Refractory...

2022-04-06 - Immunicom Announces Addition of Key Industry Leaders to ...

Immunicom Announces Addition of Key Industry Leaders to Board of Directors. Dr. Peter Farrell, founder of ResMed [NYSE: RMD], has been Chairman...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M435%N/A
#2
$5.2M430%N/A
#3
$5.4M4316%$206.8M
#4
$4.8M43N/AN/A
#5
$5M43-4%N/A